Figure raises $7.5M to help startup employees better understand their compensation

The topic of compensation has historically been a delicate one that has left many people — especially startup employees — wondering just what drives what can feel like random decisions around pay and equity. Last June, software engineers (and housemates) Miles Hobby and Geoffrey Tisserand set about trying to solve the problem for companies by […]

Beyond the fanfare and SEC warnings, SPACs are here to stay

Matt Johnson Contributor Matt Johnson is CEO and co-founder of QC Ware, a quantum computing software company. Matt was a managing director in private equity at Apollo Management and prior to that was a managing director in principal investing at Credit Suisse. The number of SPACs in the deep tech sector was skyrocketing, but a […]

Sorbet raises $6M seed led by Viola Ventures to tackle the thorny financials of paid time off

A U.S./Israeli startup, Sorbet — which is tackling what companies do with the financial risks as employees accrue paid time off (PTO) — has raised $6 million in a seed funding round led by Viola Ventures, with participation by Global Founders Capital and Meron Capital. The economics of paid time off is relatively hidden in […]

The SPAC boom isn’t just here to stay, it’s changing consumer tech

Mike Murphy Contributor Mike Murphy is the founder and CEO of Rosecliff Ventures, a New York City-based investment firm focused on venture capital and private equity opportunities. Consumer technology is an inherently risky investment sector: even the best idea can fall flat if the story of the product is not sold properly to the end […]

How to fundraise over Zoom more effectively

So far, I haven’t met a single one of my investors in person Max Greenwald 10 hours Max Greenwald Contributor Max Greenwald is the co-founder and CEO of Warmly, an app that pulls context on everyone you meet via Zoom or other video calling platforms. More posts by this contributor Protect Your Privacy & Security […]

Vista Equity takes minority stake in Canada’s Vena with $242M investment

Vena, a Canadian company focused on the Corporate Performance Management (CPM) software space, has raised $242 million in Series C funding from Vista Equity Partners. As part of the financing, Vista Equity is taking a minority stake in the company. The round follows $25 million in financing from CIBC Innovation Banking last September, and brings […]

Founders who don’t properly vet VCs set up both parties for failure

Andrés Dancausa Contributor Andrés Dancausa is fund partner, EMEA for operator-led international investors TheVentureCity. Before entering the world of VC, he was the CEO of a Spanish fintech company and launched his own startup in the edtech space. There’s a disconnect between reality and the added value investors are promising entrepreneurs. Three in five founders […]

Thoma Bravo buys cybersecurity vendor Proofpoint for $12.3B in cash

More M&A activity is underway in the red-hot field of cybersecurity. In the latest development, private equity giant Thoma Bravo is buying Proofpoint, the SaaS security vendor, for $12.3 billion in cash. Proofpoint is traded publicly on the Nasdaq exchange and as of its closing price on Friday, it had a market cap of $7.5 […]

Two investors weigh in: Is your SPAC just a PIPE dream?

Hope Cochran Contributor Hope Cochran is an investor at Madrona Venture Group, where she invests in early-stage fintech and ML/AI applications for the business environment. Ishani Ummat Contributor Ishani Ummat is an investor at Madrona Venture Group who focuses on sourcing and evaluating new investment opportunities, as well as supporting the growth and strategy of […]

2021 should be a banner year for biotech startups that make smart choices early

Michael B. Gray Contributor Michael B. Gray is partner and leader of the private equity, venture capital and growth companies practice, Neal Gerber Eisenberg. John Flavin Contributor Last year was a record 12 months for venture-backed biotech and pharma companies, with deal activity rising to $28.5 billion from $17.8 billion in 2019. As vaccines roll […]